f a prescription drug needs a hard sell, can it really be all that good?

A new analysis suggests the answer is no, at least in Canada.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • There is a reason why drug reps do not promote the drugs on the WHO EML. All of the meds on the list from what I can see are generic. With the typical pharma company paying $3000 or more a day for one rep to visit 10 docs it it doesn’t make sense for them to be pushing generics. One also might argue the definition of “essential”. For example there are no TNF inhibitors on the list for rheumatoid arthritis, just the ones I learned about when I took pharmacology 45 years ago.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.